SOAT1 and neoplasm: The authors reported that the miR-125-5p loaded nanomedicine effectively inhibited the EMT potential of HCC cells via the inhibition of STAT and the inactivation of Wnt/β-Catenin, inhibiting tumour growth in HCC-bearing mice [29].